Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

NexgenRx Inc. (V:NXG)

Business Focus: Investment Management & Fund Operators (NEC)

Sector:  Financials Industry:  Investment Management & Fund Operators
 
Company Contact
Address: 191 The West Mall, Suite 905
TORONTO ON M9C 5L6
Tel: 1-416-6953393
Website: https://www.nexgenrx.com
IR: See website
Key People
Ronald C. Loucks
President, Chief Executive Officer, Director
Kelly Ehler
Chief Financial Officer
Andrew Munroe
Senior Vice President - Pharma and Payor Partners
Business Overview
NexgenRx Inc. is a Canada-based third-party administrator and technology solutions provider. The Company is focused on building technology platforms that equip its clients with unprecedented capabilities for managing and self-managing group benefit plans, group pension plans and patient support programs. The Company offers plan sponsors, administration and health benefit technology applications in a of software-as-a-service model. The Company's products include NexSys, NexAdmin, NexPension and NexPSPAssist. The NexSys product platform provides solution and simplifies adjudication of dental, prescription drug and extended health claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. Its NexPension product is an advanced pension administration solution designed to help sponsors record and tabulate contributions for their membership group in a multi-employer environment. Its platform makes self-administration a reality.
Financial Overview
For the nine months ended 30 September 2023, NexgenRx Inc revenues increased 9% to C$10.3M. Net income decreased 84% to C$56K. Revenues reflect Administration fees increase of 40% to C$4.7M, Other Income increase from C$109K to C$391K, Consulting increase of 12% to C$1.2M. Net income was offset by Compensation and external contractors increase of 16% to C$5.7M (expense), Professional fees increase of 21% to C$265K (expense).
Employees: 20 as of Mar 31, 2006
Reporting Currency: Canadian Dollars
Enterprise value: $17.34M as of Sep 30, 2023
Annual revenue (TTM): $13.65M as of Sep 30, 2023
EBITDA (TTM): $1.17M as of Sep 30, 2023
Net annual income (TTM): -$0.31M as of Sep 30, 2023
Free cash flow (TTM): $0.15M as of Sep 30, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 70,921,820 as of Mar 20, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization